World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
58
Citations
13511
World Ranking
10525
National Ranking
2907

Kenneth L. Kirk publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Kenneth L. Kirk sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 292 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Kenneth L. Kirk D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth L. Kirk sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 58 D-Index — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Kenneth L. Kirk is affiliated with the National Institutes of Health in the United States. Their research spans several interconnected fields, including Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these disciplines, key subfields of their work include Parasitology, Infectious Diseases, Virology, Molecular Biology, and Public Health, Environmental and Occupational Health.

They have contributed to a range of topics, particularly focused on infectious agents and disease treatment strategies. Main topics of their work include:

  • Toxoplasma gondii Research Studies
  • HIV/AIDS Drug Development and Treatment
  • HIV Research and Treatment
  • Polyamine Metabolism and Applications
  • Malaria Research and Control
  • Pneumocystis jirovecii Pneumonia Detection and Treatment
  • Computational Drug Discovery Methods

Their peer-reviewed publications have appeared in frequent venues such as PLoS Pathogens, bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Scientific Reports, and the Journal of Medicinal Chemistry.

Selected recent publications include:

  • "A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin" (2022, Nature Communications)
  • "Identifying the major lactate transporter of Toxoplasma gondii tachyzoites" (2021, Scientific Reports)
  • "Substrate-mediated regulation of the arginine transporter of Toxoplasma gondii" (2021, PLoS Pathogens)
  • "An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials" (2021, Journal of Medicinal Chemistry)
  • "Coordinated action of multiple transporters in the acquisition of essential cationic amino acids by the intracellular parasite Toxoplasma gondii" (2021, PLoS Pathogens)

Kirk has collaborated frequently with several researchers, including:

  • Giel G. van Dooren
  • Adele M. Lehane
  • Esther Rajendran
  • Birte Steinhöfel
  • Deyun Qiu

Their work involves detailed investigation of parasitic protozoa such as Toxoplasma gondii and Plasmodium falciparum, focusing on mechanisms of drug resistance, transporter regulation, and amino acid acquisition by parasites. They have also engaged in computational approaches to drug discovery alongside experimental validation in antimalarial compounds.

Best Publications

  • Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments

    Kenneth L. Kirk

  • Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules

    Kenneth L. Kirk

  • Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.

    Qi Chen;Michael Graham Espey;Andrew Y. Sun;Chaya Pooput

  • Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.

    Qi Chen;Michael Graham Espey;Andrew Y. Sun;Je-Hyuk Lee

  • Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection

    Mika Scheinin;Wen-Ho Chang;Kenneth L. Kirk;Markku Linnoila

  • Accumulation of Vitamin C (Ascorbate) and Its Oxidized Metabolite Dehydroascorbic Acid Occurs by Separate Mechanisms

    Richard W. Welch;Yaohui Wang;Arthur Crossman;Jae B. Park

  • 6-Fluorocatecholamines as false adrenergic neurotransmitters.

    C C Chiueh;Z Zukowska-Grojec;K L Kirk;I J Kopin

  • Fluoronorepinephrines: specific agonists for the activation of alpha and beta adrenergic-sensitive cyclic AMP-generating systems in brain slices.

    J W Daly;W Padgett;Y Nimitkitpaisan;C R Creveling

  • Selective Fluorination in Drug Design and Development: An Overview of Biochemical Rationales

    Kenneth L Kirk

  • Positron emission tomographic imaging of cardiac sympathetic innervation and function.

    D S Goldstein;P C Chang;G Eisenhofer;R Miletich

  • Cyclic AMP-generating systems: regional differences in activation by adrenergic receptors in rat brain

    JW Daly;W Padgett;CR Creveling;D Cantacuzene

  • 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.

    Itschak Lamensdorf;Graeme Eisenhofer;Judith Harvey-White;Amotz Nechustan

  • Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors

    Dieter Ukena;Kenneth A. Jacobson;William L. Padgett;Cristina Ayala

  • Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.

    Kenneth A. Jacobson;Kenneth L. Kirk;William L. Padgett;John W. Daly

  • [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.

    Kenneth A. Jacobson;Dieter Ukena;Kenneth L. Kirk;John W. Daly

  • Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity.

    Hideko Nagasawa;Yoshihiro Uto;Hideyuki Sasaki;Natsuko Okamura

  • Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde.

    I. Lamensdorf;G. Eisenhofer;J. Harvey-White;Y. Hayakawa

  • Identification of arsenic-binding proteins in human breast cancer cells

    Xinyan Zhang;Fan Yang;Joong-Youn Shim;Kenneth L. Kirk

  • Facile synthesis of 2-substituted imidazoles

    Kenneth L. Kirk

  • Enantioselective Fluorination Mediated by N-Fluoroammonium Salts of Cinchona Alkaloids: First Enantioselective Synthesis of BMS-204352 (MaxiPost)

    Norio Shibata;Takehisa Ishimaru;Emiko Suzuki;Kenneth L Kirk

Frequent Co-Authors

Kenneth A. Jacobson
Kenneth A. Jacobson National Institutes of Health
John W. Daly
John W. Daly National Institutes of Health
Irwin J. Kopin
Irwin J. Kopin National Institutes of Health
Norio Shibata
Norio Shibata Nagoya Institute of Technology
Markku Linnoila
Markku Linnoila University of Helsinki
David S. Goldstein
David S. Goldstein National Institutes of Health
David C. Klein
David C. Klein National Institutes of Health
Robert S. Phillips
Robert S. Phillips University of Georgia
Roland Fröhlich
Roland Fröhlich University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of online degrees and rewarding career paths. For those interested in integrating legal aspects alongside scientific knowledge, exploring the best online associate degree programs in criminal justice can provide foundational skills relevant to forensic chemistry and law enforcement.

Additionally, pursuing a paralegal degree offers pathways into legal support roles, where chemical expertise might assist in patent law or intellectual property cases related to pharmaceuticals or chemical inventions.

For chemistry graduates interested in the healthcare sector, becoming a pharmaceutical sales rep is a dynamic option. Discover more about how to become a pharmaceutical sales rep-salary and career paths to blend scientific knowledge with strong communication and business skills.

Lastly, for those seeking a more clinical or research-oriented role, following the steps to become a pharmacist offers a clear roadmap to a respected career in medication management, healthcare, and patient counseling that relies heavily on chemical expertise.

Best Scientists Citing Kenneth L. Kirk

Trending Scientists

Recently Published Articles